While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Pharma giant targets new standards of care
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
By cutting pain crises & boosting haemoglobin
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
The new facility is expected to significantly improve access to high-quality medical services for patients across Gujarat and neighbouring regions
Subscribe To Our Newsletter & Stay Updated
